Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 277

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Anti–Melanoma Differentiation–Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic Dermatomyositis

Open access
Moghadam‐Kia, Siamak, Oddis, Chester V., Sato, Shinji, Kuwana, Masataka, Aggarwal, Rohit·2016·Arthritis Care & Research

Abstract

Objective: Clinically amyopathic dermatomyositis (CADM) is a subset of dermatomyositis (DM) presenting with the characteristic rash of DM without objective muscle weakness. Asian studies report that anti–melanoma differentiation–associated gene 5 (anti–MDA‐5) autoantibody in CADM is associated with interstitial lung disease (ILD), particularly rapidly progressive ILD (RPILD). These associations have not been established in US myositis patients. The goal of our study was to determine the association of anti–MDA‐5 autoantibody with ILD, RPILD, and survival in US patients with CADM and classic DM. Methods: CADM patients were identified in the University of Pittsburgh Myositis Center Database and matched 1:1 (sex and age) to classic DM controls. Anti–MDA‐5 was measured by serum enzyme‐linked immunosorbent assay. Kaplan‐Meier, log rank, and chi‐square tests were used for analysis. Results: We identified 61 CADM patients (62% women, mean age 48.2 years) and 61 classic DM controls (64% women, mean age 44.8 years). The frequencies of anti–MDA‐5 positivity, ILD, and RPILD were similar in the 2 cohorts (MDA‐5 positive: CADM 13.1% [8 of 61] and DM 13.1% [8 of 61], ILD positive: CADM 31.1% [19 of 61] and DM 26.2% [16 of 61], and RPILD positive: CADM 8.2% [5 of 61] and DM 5% [3 of 61]; P = 1, 0.55, and 0.46, respectively). Anti–MDA‐5 positivity was significantly associated with ILD, since 50% of MDA‐5–positive subjects (8 of 16) had ILD versus 25.5% of MDA‐5–negative subjects (27 of 106; P = 0.04). Anti–MDA‐5 was strongly associated with RPILD (P < 0.001). Anti–MDA‐5–positive patients with ILD had worse baseline pulmonary function testing variables compared to anti–MDA‐5–negative patients. Anti–MDA‐5 positivity was significantly associated with poor survival (P = 0.007). Conclusion: Anti–MDA‐5 antibody is significantly associated with ILD, RPILD, worse pulmonary outcome, and survival in US classic DM and CADM patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/acr.22728

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Research works printed but not linked: 2

  1. Nagata K, 2011, Four cases of interstitial pneumonia associated with amyopathic dermatomyositis characterized by the anti‐CADM‐140 antibody, Nihon Kokyuki Gakkai Zasshi, 49, 30
  2. 10.1371/journal.pone.0098824 · doi:10.1371/journal.pone.0098824

Cited by

See all 277

Metadata

Authors
Moghadam‐Kia, S., Oddis, C. V., Sato, S., Kuwana, M., & Aggarwal, R.
Venue
Arthritis Care & Research
Publisher
Wiley
Published
2016-04-27
Volume
68
Issue
5
Pages
689-694
ISSN
  • 0893-7524 (ISSN-L)
  • 2151-464X
  • 2151-4658
OpenAlex
W2344270752
Cited by
277
References
15
FWCI
13.53
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Anti–Melanoma Differentiation–Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic Dermatomyositis. https://app.cochat.ai/papers/10.1002/acr.22728
The paper
Moghadam‐Kia, S., Oddis, C. V., Sato, S., Kuwana, M., & Aggarwal, R. (2016). Anti–Melanoma Differentiation–Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic Dermatomyositis. Arthritis Care & Research. https://doi.org/10.1002/acr.22728

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.